0001103021-20-000125.txt : 20200811
0001103021-20-000125.hdr.sgml : 20200811
20200811165310
ACCESSION NUMBER: 0001103021-20-000125
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200807
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Jeffrey Allen
CENTRAL INDEX KEY: 0001500210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 201093106
MAIL ADDRESS:
STREET 1: KING PHARMACEUTICALS, INC.
STREET 2: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_159717917539790.xml
FORM 4
X0306
4
2020-08-07
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001500210
Bailey Jeffrey Allen
4131 PARKLAKE AVE.
SUITE 225
RALEIGH
NC
27612
1
1
0
0
Chief Executive Officer
Common Stock
2020-08-07
4
M
0
5567
0
A
5567
D
Restricted Stock Units
0.0
2020-08-07
4
M
0
5567
0
D
2021-08-06
Common Stock
5567.0
5567
D
The restricted stock units ("RSUs") were issued to the Reporting Person on July 30, 2020, as compensation for service on the Issuer's board of directors. The remaining RSUs will vest in the first open window following the Company's 2021 Annual Meeting of Stockholders.
Jeffrey A Bailey
2020-08-11